vs
CHEGG, INC（CHGG）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
CHEGG, INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.0倍（$72.7M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -49.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -35.4%）
Chegg是一家总部位于美国加利福尼亚州圣克拉拉的教育科技公司，依托人工智能技术，为学生提供作业辅导、数字及实体教材租赁、在线辅导等各类学生服务，目前拥有660万订阅用户，也因被指协助学生作弊、违反学术诚信而广受批评。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CHGG vs RIGL — 直观对比
营收规模更大
CHGG
是对方的1.0倍
$69.8M
营收增速更快
RIGL
高出70.6%
-49.4%
两年增速更快
RIGL
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $72.7M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | 57.3% | 91.5% |
| 营业利润率 | -47.2% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | -49.4% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $-0.30 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHGGRIGL
| Q4 25 | $72.7M | $69.8M | ||
| Q3 25 | $77.7M | $69.5M | ||
| Q2 25 | $105.1M | $101.7M | ||
| Q1 25 | $121.4M | $53.3M | ||
| Q4 24 | $143.5M | $57.6M | ||
| Q3 24 | $136.6M | $55.3M | ||
| Q2 24 | $163.1M | $36.8M | ||
| Q1 24 | $174.3M | $29.5M |
净利润CHGGRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $-17.5M | $27.9M | ||
| Q2 25 | $-35.7M | $59.6M | ||
| Q1 25 | $-17.5M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $-212.6M | $12.4M | ||
| Q2 24 | $-616.9M | $-1.0M | ||
| Q1 24 | $-1.4M | $-8.2M |
毛利率CHGGRIGL
| Q4 25 | 57.3% | 91.5% | ||
| Q3 25 | 59.2% | 93.2% | ||
| Q2 25 | 66.3% | 95.6% | ||
| Q1 25 | 55.5% | 91.7% | ||
| Q4 24 | 68.2% | 89.9% | ||
| Q3 24 | 68.2% | 85.5% | ||
| Q2 24 | 72.2% | 92.4% | ||
| Q1 24 | 73.3% | 93.1% |
营业利润率CHGGRIGL
| Q4 25 | -47.2% | 33.2% | ||
| Q3 25 | -22.0% | 40.9% | ||
| Q2 25 | -34.7% | 60.1% | ||
| Q1 25 | -23.9% | 23.9% | ||
| Q4 24 | -19.0% | 28.9% | ||
| Q3 24 | -162.7% | 25.4% | ||
| Q2 24 | -297.3% | 1.2% | ||
| Q1 24 | -1.4% | -23.6% |
净利率CHGGRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | -22.5% | 40.2% | ||
| Q2 25 | -33.9% | 58.6% | ||
| Q1 25 | -14.4% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | -155.7% | 22.5% | ||
| Q2 24 | -378.1% | -2.8% | ||
| Q1 24 | -0.8% | -27.9% |
每股收益（稀释后）CHGGRIGL
| Q4 25 | $-0.30 | $14.11 | ||
| Q3 25 | $-0.16 | $1.46 | ||
| Q2 25 | $-0.33 | $3.28 | ||
| Q1 25 | $-0.17 | $0.63 | ||
| Q4 24 | $-0.03 | $0.82 | ||
| Q3 24 | $-2.05 | $0.70 | ||
| Q2 24 | $-6.01 | $-0.06 | ||
| Q1 24 | $-0.01 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.8M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $119.6M | $391.5M |
| 总资产 | $278.0M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CHGGRIGL
| Q4 25 | $72.8M | $155.0M | ||
| Q3 25 | $96.4M | $137.1M | ||
| Q2 25 | $85.6M | $108.4M | ||
| Q1 25 | $88.3M | $77.1M | ||
| Q4 24 | $315.7M | $77.3M | ||
| Q3 24 | $361.1M | $61.1M | ||
| Q2 24 | $345.5M | $49.1M | ||
| Q1 24 | $390.8M | $49.5M |
总债务CHGGRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CHGGRIGL
| Q4 25 | $119.6M | $391.5M | ||
| Q3 25 | $146.1M | $117.6M | ||
| Q2 25 | $157.9M | $81.9M | ||
| Q1 25 | $185.7M | $18.6M | ||
| Q4 24 | $193.0M | $3.3M | ||
| Q3 24 | $185.0M | $-14.6M | ||
| Q2 24 | $365.5M | $-29.9M | ||
| Q1 24 | $963.5M | $-31.7M |
总资产CHGGRIGL
| Q4 25 | $278.0M | $513.6M | ||
| Q3 25 | $378.3M | $242.5M | ||
| Q2 25 | $404.5M | $206.7M | ||
| Q1 25 | $438.8M | $176.0M | ||
| Q4 24 | $869.0M | $164.0M | ||
| Q3 24 | $1.0B | $139.4M | ||
| Q2 24 | $1.1B | $128.4M | ||
| Q1 24 | $1.7B | $126.5M |
负债/权益比CHGGRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-15.5M | — |
| 自由现金流率自由现金流/营收 | -21.3% | — |
| 资本支出强度资本支出/营收 | 8.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-12.6M | — |
8季度趋势，按日历期对齐
经营现金流CHGGRIGL
| Q4 25 | $-9.0M | $22.0M | ||
| Q3 25 | $4.8M | $24.0M | ||
| Q2 25 | $-4.8M | $30.5M | ||
| Q1 25 | $24.5M | $-893.0K | ||
| Q4 24 | $18.1M | $14.5M | ||
| Q3 24 | $39.5M | $21.7M | ||
| Q2 24 | $14.2M | $302.0K | ||
| Q1 24 | $53.3M | $-5.0M |
自由现金流CHGGRIGL
| Q4 25 | $-15.5M | — | ||
| Q3 25 | $-943.0K | — | ||
| Q2 25 | $-12.1M | — | ||
| Q1 25 | $15.9M | — | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $23.7M | — | ||
| Q2 24 | $-3.6M | — | ||
| Q1 24 | $25.3M | — |
自由现金流率CHGGRIGL
| Q4 25 | -21.3% | — | ||
| Q3 25 | -1.2% | — | ||
| Q2 25 | -11.5% | — | ||
| Q1 25 | 13.1% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 17.3% | — | ||
| Q2 24 | -2.2% | — | ||
| Q1 24 | 14.5% | — |
资本支出强度CHGGRIGL
| Q4 25 | 8.9% | — | ||
| Q3 25 | 7.4% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 7.1% | — | ||
| Q4 24 | 9.3% | — | ||
| Q3 24 | 11.6% | — | ||
| Q2 24 | 10.9% | — | ||
| Q1 24 | 16.1% | — |
现金转化率CHGGRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
